Evidence map›Paper›PMID 29271098›Full record

ReviewPlant biotechnology journal2018

A guide to the contained use of plant virus infectious clones.

Helen C Brewer, Diane L Hird, Andy M Bailey, Susan E Seal, Gary D Foster

Open access · goldAbstract readReview
In one paragraph

Review in Plant biotechnology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Local citrus sudden death-associated virus infection inThe Journal of general virology · 2026
    Article
  3. Review
  4. Development of a Reverse Genetics System for Rice Tiller Inhibition Virus.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Plant-made pharmaceuticals.Plant biotechnology (Tokyo, Japan) · 2024
    Article
  10. Article
  11. Article
  12. Viruses of Yams (Viruses · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Helen C BrewerSchool of Biological Sciences, University of Bristol, Bristol, UK.
Diane L HirdSchool of Biological Sciences, University of Bristol, Bristol, UK.ORCID 0000-0001-8425-7708
Andy M BaileySchool of Biological Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-7594-3703
Susan E SealNatural Resources Institute, University of Greenwich, Chatham Maritime, Kent, UK.ORCID 0000-0002-3952-1562
Gary D FosterSchool of Biological Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-1979-1397
University of Bristol · GBNatural Resources Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/GCRF-IAA/03Biotechnology and Biological Sciences Research Council BB/GCRF-IAA/17/03Biotechnology and Biological Sciences Research Council BB/R005397/1
6 · The paper itself

Abstract

Plant virus infectious clones are important tools with wide-ranging applications in different areas of biology and medicine. Their uses in plant pathology include the study of plant-virus interactions, and screening of germplasm as part of prebreeding programmes for virus resistance. They can also be modified to induce transient plant gene silencing (Virus Induced Gene Silencing - VIGS) and as expression vectors for plant or exogenous proteins, with applications in both plant pathology and more generally for the study of plant gene function. Plant viruses are also increasingly being investigated as expression vectors for in planta production of pharmaceutical products, known as molecular farming. However, plant virus infectious clones may pose a risk to the environment due to their ability to reconstitute fully functional, transmissible viruses. These risks arise from both their inherent pathogenicity and the effect of any introduced genetic modifications. Effective containment measures are therefore required. There has been no single comprehensive review of the biosafety considerations for the contained use of genetically modified plant viruses, despite their increasing importance across many biological fields. This review therefore explores the biosafety considerations for working with genetically modified plant viruses in contained environments, with focus on plant growth facilities. It includes regulatory frameworks, risk assessment, assignment of biosafety levels, facility features and working practices. The review is based on international guidance together with information provided by plant virus researchers.

Indexed as

Microorganisms, Genetically-ModifiedContainment of BiohazardsEquipment and SuppliesGenetic VectorsLaboratoriesPlant VirusesPlasmidsRisk AssessmentVirologybiosafety levelcontainmentGMOinfectious cloneplant virus

Identifiers

PMID29271098
PMCPMC5867029
OpenAlexW2777817804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.